Cargando…
Hospital use of systemic antifungal drugs
BACKGROUND: Sales data indicate a major increase in the prescription of antifungal drugs in the last two decades. Many new agents for systemic use that only recently have become available are likely to be prescribed intensively in acute care hospitals. Sales data do not adequately describe the devel...
Autores principales: | de With, Katja, Steib-Bauert, Michaela, Knoth, Holger, Dörje, Frank, Strehl, Egid, Rothe, Ulrich, Maier, Ludwig, Kern, Winfried V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549558/ https://www.ncbi.nlm.nih.gov/pubmed/15703083 http://dx.doi.org/10.1186/1472-6904-5-1 |
Ejemplares similares
-
Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center
por: Borde, Johannes P, et al.
Publicado: (2014) -
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial
por: Dürr, Pauline, et al.
Publicado: (2022) -
Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care
por: Koller, Anna Katharina, et al.
Publicado: (2020) -
Antifungal Drugs
por: Houšť, Jiří, et al.
Publicado: (2020) -
Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate
por: Schuster, Sabine, et al.
Publicado: (2021)